Deep learning (DL) models are becoming pervasive and applicable to computer vision, image processing, and synthesis problems. The performance of these models is often improved through architectural configuration, tweaks, the use of enormous training data, and skillful selection of hyperparameters. The application of deep learning models to medical image processing has yielded interesting performance, capable of correctly detecting abnormalities in medical digital images, making them surpass human physicians. However, advancing research in this domain largely relies on the availability of training datasets. These datasets are sometimes not publicly accessible, insufficient for training, and may also be characterized by a class imbalance among samples. As a result, inadequate training samples and difficulty in accessing new datasets for training deep learning models limit performance and research into new domains. Hence, generative adversarial networks (GANs) have been proposed to mediate this gap by synthesizing data similar to real sample images. However, we observed that benchmark datasets with regions of interest (ROIs) for characterizing abnormalities in breast cancer using digital mammography do not contain sufficient data with a fair distribution of all cases of abnormalities. For instance, the architectural distortion and breast asymmetry in digital mammograms are sparsely distributed across most publicly available datasets. This paper proposes a GAN model, named ROImammoGAN, which synthesizes ROI-based digital mammograms. Our approach involves the design of a GAN model consisting of both a generator and a discriminator to learn a hierarchy of representations for abnormalities in digital mammograms. Attention is given to architectural distortion, asymmetry, mass, and microcalcification abnormalities so that training distinctively learns the features of each abnormality and generates sufficient images for each category. The proposed GAN model was applied to MIAS datasets, and the performance evaluation yielded a competitive accuracy for the synthesized samples. In addition, the quality of the images generated was also evaluated using PSNR, SSIM, FSIM, BRISQUE, PQUE, NIQUE, FID, and geometry scores. The results showed that ROImammoGAN performed competitively with state-of-the-art GANs. The outcome of this study is a model for augmenting CNN models with ROI-centric image samples for the characterization of abnormalities in breast images.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008034 | PMC |
http://dx.doi.org/10.1038/s41598-022-09929-9 | DOI Listing |
Br J Radiol
December 2024
Breast Imaging Division, Radiology Department, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy.
Neoadjuvant Therapy (NT) has become the gold standard for treating locally advanced Breast Cancer (BC). The assessment of pathological response (pR) post-NT plays a crucial role in predicting long-term survival, with Contrast-Enhanced Magnetic Resonance Imaging (MRI) currently recognised as the preferred imaging modality for its evaluation. Traditional imaging techniques, such as Digital Mammography (DM) and Ultrasonography (US), encounter difficulties in post-NT assessments due to breast density, lesion changes, fibrosis, and molecular patterns.
View Article and Find Full Text PDFEur Radiol
December 2024
Radiology Diagnostics, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden.
Objectives: Limited understanding exists regarding non-detected cancers in digital breast tomosynthesis (DBT) screening. This study aims to classify non-detected cancers into true or false negatives, compare them with true positives, and analyze reasons for non-detection.
Materials And Methods: Conducted between 2010 and 2015, the prospective single-center Malmö Breast Tomosynthesis Screening Trial (MBTST) compared one-view DBT and two-view digital mammography (DM).
J Med Imaging (Bellingham)
January 2025
Siemens Healthineers AG, Forchheim, Germany.
Purpose: Digital breast tomosynthesis (DBT) has been introduced more than a decade ago. Studies have shown higher breast cancer detection rates and lower recall rates, and it has become an established imaging method in diagnostic settings. However, full-field digital mammography (FFDM) remains the most common imaging modality for screening in many countries, as it delivers high-resolution planar images of the breast.
View Article and Find Full Text PDFBackground: Breast density is a strong predictor of breast cancer. However, the difference in risk between breast density categories C and D remains inadequately explored. Given the low occurrence of extremely dense breasts, this investigation is crucial because it may lead to modifications in screening techniques for those with these conditions.
View Article and Find Full Text PDFIndian J Radiol Imaging
January 2025
Department of Radiodiagnosis and Interventional Radiology, All India Institute of Medical Sciences, New Delhi, India.
Synthesized mammography (SM) refers to two-dimensional (2D) images derived from the digital breast tomosynthesis (DBT) data. It can reduce the radiation dose and scan duration when compared with conventional full-field digital mammography (FFDM) plus tomosynthesis. To compare the diagnostic performance of 2D FFDM with synthetic mammograms obtained from DBT in a diagnostic population.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!